Enter your information to understand your ALP levels.

The History of Alkaline Phosphatase

Alkaline phosphatase was first described in 1923 by British biochemist Robert Robison, working at the Lister Institute in London, who identified the enzyme while investigating how bone tissue mineralizes. Robison proposed that the enzyme helped liberate phosphate ions from organic compounds in the bloodstream, making them available to form the calcium phosphate crystals that harden developing bone — a theory that held up remarkably well against decades of later research. Clinical interest in measuring the enzyme grew through the 1920s and 1930s as physicians realized its levels rose sharply in certain bone and liver conditions, eventually making it one of the earliest enzyme tests adopted into routine laboratory medicine, well before most other enzymes were even known to be clinically useful.

What Alkaline Phosphatase Actually Is

Alkaline phosphatase is an enzyme present throughout the body, though it is most concentrated in the liver, bones, bile ducts, intestines, and placenta during pregnancy. Its job is to remove phosphate groups from other molecules, a chemical reaction that works best in alkaline conditions — hence the name. In bone, it is produced by osteoblasts, the cells responsible for building new bone tissue, where it plays a direct role in the mineralization process that gives bone its hardness. In the liver, it is concentrated near the bile ducts, so blood levels commonly rise when bile flow is obstructed or the ducts are inflamed, making it a useful signal of several different underlying conditions depending on which tissue is producing the excess. Children and teenagers naturally run higher levels than adults simply because their bones are still actively growing.

How Alkaline Phosphatase Is Measured

Standard laboratory testing uses a colorimetric enzymatic assay: a colorless substrate is added to the blood sample, and alkaline phosphatase converts it into a yellow compound whose intensity is measured with a spectrophotometer and directly reflects enzyme activity. This method was standardized internationally by the International Federation of Clinical Chemistry to ensure consistent results across different laboratories and equipment, replacing a patchwork of older techniques that made comparing results between hospitals unreliable. Because elevated alkaline phosphatase can originate from bone, liver, or other tissue, doctors sometimes order a follow-up test called isoenzyme electrophoresis, which separates the different tissue-specific forms of the enzyme to pinpoint its true source when the reason for an abnormal result isn't otherwise clear.

Scientists Behind the Science

Robert Robison's 1923 discovery remains the foundational moment for this biomarker, directly linking a measurable blood enzyme to the physical process of bone formation for the first time. A few years later, American biochemist Aaron Bodansky developed a practical clinical method for measuring serum phosphatase activity in the 1930s, and the resulting "Bodansky unit" became the standard way doctors reported results for decades before the modern enzymatic assay replaced it. Around the same period, Cyrus Fiske and Yellapragada Subbarow developed a colorimetric technique for measuring phosphate concentrations that underpinned much of the era's enzyme chemistry, providing essential groundwork that later researchers built on to refine alkaline phosphatase testing into the fast, standardized assay used in clinical laboratories today, more than a century after Robison's original observation.